S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
The single greatest medical breakthrough of all time? (Ad)
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
Options Trading Plan–Perfect For Beginners (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Options Trading Plan–Perfect For Beginners (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Canadian autoworkers ratify new labor agreement with Ford
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
The single greatest medical breakthrough of all time? (Ad)
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
Options Trading Plan–Perfect For Beginners (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Options Trading Plan–Perfect For Beginners (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Canadian autoworkers ratify new labor agreement with Ford
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
The single greatest medical breakthrough of all time? (Ad)
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
Options Trading Plan–Perfect For Beginners (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Options Trading Plan–Perfect For Beginners (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Canadian autoworkers ratify new labor agreement with Ford
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
The single greatest medical breakthrough of all time? (Ad)
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
Options Trading Plan–Perfect For Beginners (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Options Trading Plan–Perfect For Beginners (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Canadian autoworkers ratify new labor agreement with Ford
NYSE:ELAN

Elanco Animal Health (ELAN) Stock Forecast, Price & News

$11.25
-0.08 (-0.71%)
(As of 09/22/2023 ET)
Compare
Today's Range
$11.23
$11.41
50-Day Range
$11.25
$12.63
52-Week Range
$7.88
$14.69
Volume
2.56 million shs
Average Volume
4.52 million shs
Market Capitalization
$5.54 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.10

Elanco Animal Health MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
34.2% Upside
$15.10 Price Target
Short Interest
Healthy
2.10% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-4.69
Upright™ Environmental Score
News Sentiment
1.25mentions of Elanco Animal Health in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
8.24%
From $0.85 to $0.92 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.06 out of 5 stars

Medical Sector

515th out of 963 stocks

Pharmaceutical Preparations Industry

238th out of 458 stocks


ELAN stock logo

About Elanco Animal Health (NYSE:ELAN) Stock

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. The company was founded in 1954 and is headquartered in Greenfield, Indiana.

ELAN Price History

ELAN Stock News Headlines

30 Most Owned Dog Breeds in America
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Elanco Animal Health (ELAN) Receives a Hold from J.P. Morgan
Elanco Animal Health (ELAN) Receives a New Rating from Barclays
Q2 2023 Elanco Animal Health Inc Earnings Call
Elanco Animal Health Posts Lower 2Q Sales
Earnings Outlook For Elanco Animal Health
See More Headlines
Receive ELAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elanco Animal Health and its competitors with MarketBeat's FREE daily newsletter.

ELAN Company Calendar

Last Earnings
8/07/2023
Today
9/24/2023
Next Earnings (Estimated)
11/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
9,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$15.10
High Stock Price Forecast
$20.00
Low Stock Price Forecast
$9.50
Forecasted Upside/Downside
+34.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
6 Analysts

Profitability

Net Income
$-78,000,000.00
Pretax Margin
-2.40%

Debt

Sales & Book Value

Annual Sales
$4.42 billion
Cash Flow
$2.59 per share
Book Value
$15.37 per share

Miscellaneous

Free Float
461,145,000
Market Cap
$5.54 billion
Optionable
Optionable
Beta
1.01
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Jeffrey N. SimmonsMr. Jeffrey N. Simmons (Age 56)
    Pres, CEO & Director
    Comp: $2.51M
  • Mr. Todd S. YoungMr. Todd S. Young (Age 51)
    Exec. VP & CFO
    Comp: $1.14M
  • Dr. Ramiro Martin Cabral (Age 51)
    Exec. VP & Pres of Elanco International
    Comp: $972.82k
  • Dr. Ellen de Brabander Ph.D. (Age 60)
    Exec. VP of Innovation, Regulatory & Bus. Devel.
    Comp: $1.13M
  • Mr. Rajeev  ModiMr. Rajeev Modi (Age 42)
    Exec. VP of U.S. Pet Health & Global Digital Transformation
    Comp: $1.32M
  • Mr. James M. Meer (Age 53)
    Sr. VP & Chief Accounting Officer
  • Mr. Chris Keeley
    Sr. VP & Chief Information Officer
  • Mr. David S. Kinard (Age 56)
    Exec. VP of HR, Corp. Communications & Admin.
  • Katy Grissom
    Head of Investor Relations
  • Ms. Marcela A. Kirberger (Age 56)
    Exec. VP, Gen. Counsel & Corp. Sec.













ELAN Stock - Frequently Asked Questions

Should I buy or sell Elanco Animal Health stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Elanco Animal Health in the last twelve months. There are currently 1 sell rating, 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ELAN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ELAN, but not buy additional shares or sell existing shares.
View ELAN analyst ratings
or view top-rated stocks.

What is Elanco Animal Health's stock price forecast for 2023?

6 Wall Street analysts have issued 1-year target prices for Elanco Animal Health's stock. Their ELAN share price forecasts range from $9.50 to $20.00. On average, they predict the company's stock price to reach $15.10 in the next year. This suggests a possible upside of 34.2% from the stock's current price.
View analysts price targets for ELAN
or view top-rated stocks among Wall Street analysts.

How have ELAN shares performed in 2023?

Elanco Animal Health's stock was trading at $12.22 at the beginning of 2023. Since then, ELAN shares have decreased by 7.9% and is now trading at $11.25.
View the best growth stocks for 2023 here
.

Are investors shorting Elanco Animal Health?

Elanco Animal Health saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 10,360,000 shares, an increase of 10.2% from the August 15th total of 9,400,000 shares. Based on an average trading volume of 5,800,000 shares, the days-to-cover ratio is presently 1.8 days.
View Elanco Animal Health's Short Interest
.

When is Elanco Animal Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our ELAN earnings forecast
.

How were Elanco Animal Health's earnings last quarter?

Elanco Animal Health Incorporated (NYSE:ELAN) issued its earnings results on Monday, August, 7th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.05 by $0.13. The company earned $1.06 billion during the quarter, compared to analyst estimates of $1.04 billion. Elanco Animal Health had a positive trailing twelve-month return on equity of 6.93% and a negative net margin of 2.24%. The company's revenue for the quarter was down 10.2% compared to the same quarter last year. During the same period last year, the company earned $0.36 EPS.

What guidance has Elanco Animal Health issued on next quarter's earnings?

Elanco Animal Health updated its third quarter 2023 earnings guidance on Monday, August, 7th. The company provided earnings per share guidance of $0.08-$0.13 for the period, compared to the consensus estimate of $0.16. The company issued revenue guidance of $1.02 billion-$1.06 billion, compared to the consensus revenue estimate of $1.04 billion.

What is Jeff Simmons' approval rating as Elanco Animal Health's CEO?

169 employees have rated Elanco Animal Health Chief Executive Officer Jeff Simmons on Glassdoor.com. Jeff Simmons has an approval rating of 89% among the company's employees.

What other stocks do shareholders of Elanco Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Elanco Animal Health investors own include NVIDIA (NVDA), AbbVie (ABBV), Micron Technology (MU), QUALCOMM (QCOM), Walt Disney (DIS), Johnson & Johnson (JNJ), AT&T (T), Cisco Systems (CSCO), CVS Health (CVS) and Bristol-Myers Squibb (BMY).

When did Elanco Animal Health IPO?

(ELAN) raised $1.4 billion in an initial public offering on Thursday, September 20th 2018. The company issued 62,900,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Barclays, BNP PARIBAS, BofA Merrill Lynch, Citigroup, Credit Suisse, Deutsche Bank Securities, Evercore ISI, Cowen, Academy Securities, Drexel Hamilton, Mischler Financial Group, Ramirez and The Williams Capital Group were co-managers.

What is Elanco Animal Health's stock symbol?

Elanco Animal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "ELAN."

Who are Elanco Animal Health's major shareholders?

Elanco Animal Health's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (5.51%), Shapiro Capital Management LLC (4.14%), Black Creek Investment Management Inc. (2.79%), State Street Corp (1.97%), Goldman Sachs Group Inc. (1.83%) and Geode Capital Management LLC (1.36%). Insiders that own company stock include Aktiengesellschaft Bayer, Art A Garcia, Elanco Animal Health Inc, Jeffrey N Simmons, John P Bilbrey, Michael J Harrington, R David Hoover and Rajeev A Modi.
View institutional ownership trends
.

How do I buy shares of Elanco Animal Health?

Shares of ELAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Elanco Animal Health's stock price today?

One share of ELAN stock can currently be purchased for approximately $11.25.

How much money does Elanco Animal Health make?

Elanco Animal Health (NYSE:ELAN) has a market capitalization of $5.54 billion and generates $4.42 billion in revenue each year. The company earns $-78,000,000.00 in net income (profit) each year or ($0.20) on an earnings per share basis.

How many employees does Elanco Animal Health have?

The company employs 9,000 workers across the globe.

How can I contact Elanco Animal Health?

Elanco Animal Health's mailing address is 2500 INNOVATION WAY, GREENFIELD IN, 46140. The official website for the company is www.elanco.com. The company can be reached via phone at (877) 352-6261 or via email at kanaga_tiffany@elanco.com.

This page (NYSE:ELAN) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -